Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe

CompletedOBSERVATIONAL
Enrollment

249

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
HIV Infection
Trial Locations (9)

Unknown

Hospital St Pierre, Brussels

German Competence Network, Frankfurt

Italian Register for HIV-infection in Children, Florence

Victor Babes Hospital, Bucharest

Spanish Perinatal Cohort, Barcelona

Madrid Paediatric HIV Cohort, Madrid

Swiss Mother and Child HIV Cohort, Basel

Collaborative HIV Paediatric Study, London

European Collaborative Study, London

Sponsors
All Listed Sponsors
collaborator

PENTA Foundation

NETWORK

lead

Bristol-Myers Squibb

INDUSTRY

NCT01389310 - Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe | Biotech Hunter | Biotech Hunter